Advisers approve use of stimulant on healthy children in ADHD study

FDA advisers have recommended the agency allow researchers to use an experimental stimulant on otherwise healthy children, in order to learn more about attention deficit hyperactivity disorder. The recommendation noted that children diagnosed with ADHD also would be given 10 mg of dextroamphetamine and that the benefits to science outweigh what the advisers considered a minimal risk to the children. An FDA official noted the final decision on whether to proceed or not rests with Secretary of Health and Human Services Tommy Thompson.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN